Exhaled particle size index – from bench to bedside.
Dr. Katharina Schwarz, Fraunhofer ITEM, Hannover, Germany
Multinuclear functional lung magnetic resonance imaging - seeing is believing.
Prof. Jens Vogel-Claussen, Department of Interventional and Diagnostic Radiology, Hannover Medical School, Hannover, Germany
Facial thermography to study PK/PD relations in patients with seasonal allergic rhinitis.
Dr. Michael Larbig, Clinical Pharmacology and Translational Development, CSL Behring, Bern, Switzerland
Sputum analysis – first generation experience and next generation chipcytometry to understand airway inflammation.
Dr. Olaf Holz, Fraunhofer ITEM, Hannover, Germany
Blotting and Scraping the airways: Prospect for precision medicine for airways disease.
Prof. Trevor Hansel, Imperial Clinical Respiratory Research Unit (ICRRU), St Mary's Hospital, London, UK
Inhaled recombinant SP-C surfactant – novel device and clinical development for an old drug.
Dr. Gerhard Pohlmann, Fraunhofer ITEM, Hannover, Germany
Role of airway basal cells in chronic lung diseases.
Prof. Antje Prasse, Clinical and Translational Fibrosis Research, Fraunhofer ITEM and Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany
Data-driven phenotypes of (severe) asthma: U-BIOPRED.
Prof. Peter J. Sterk, University of Amsterdam Medical Center, Amsterdam, The Netherlands
Big data in lung research: from GWAs to systems medicine.
Prof. Thomas Illig, Hannover Unified Biobank and Institute for Human Genetics, Hannover Medical School, Hannover, Germany
Innate lymphoid cells (ILC) 2 – allergen-induced activation and migration to the lungs.
Dr. Carla Winkler, Research and Early Development - Respiratory, Inflammation and Autoimmune, AstraZeneca, Mölndal, Sweden
Development of asthma treatments – past, presence and future.
Prof. Veit Erpenbeck, Therapeutic Area Respiratory, Roche Pharma Research & Early Development, Basel, Switzerland